Increased BRAF copy number in lung adenocarcinoma

Oncology Letters

Volumn 9, Issue 2, 2015, Pages 709-712

  Sasaki, Hidefumi ^a   Maekawa, Masahiko ^b   Tatematsu, Tsutomu ^a   Okuda, Katsuhiro ^a   Moriyama, Satoru ^a   Yano, Motoki ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b GSP Lab Inc   (Japan)

Author keywords

Adnocarcinoma; BRAF; Copy number; Lung cancer; V600E

Indexed keywords

B RAF KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

ARTICLE; CHROMOSOME 7; CLINICAL ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; POINT MUTATION; POLYMERASE CHAIN REACTION;

EID: 84918791820     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2719     Document Type: Article

References (30)

1. Ginsberg RJ, Kris MK and Armstrong JG: Cancer of the lung. In: Principles and Practice of Oncology. 4th edition. JB Lippincott, Philadelphia, PA, pp 673-682, 1993.
2. Amano J, Kuwano H and Yokomise H: Thoracic and cardiovascular surgery in Japan during 2011: Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 61: 578-607, 2013.
3. Postus PE: Chemotherapy for non-small cell lung cancer: the experience of the Lung Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. Chest 113 (Suppl 1): 28S-31S, 1997.
4. Ding L, Getz G, Wheeler DA, et al: Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455: 1069-1075, 2008.
5. Sun Y, Ren Y, Fang Z, et al: Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases. J Clin Oncol 28: 4616-4620, 2010.
6. Weir BA, Woo MS, Getz G, et al: Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893-898, 2007.
7. Gautschi O, Pauli C, Srobel K, et al: A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib. J Thorac Oncol 7: e23-e24, 2012.
8. Falchook GS, Long GV, Kurzrock R, et al: Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumors: a phase 1 dose-escalation trial. Lancet 379: 1893-1901, 2012.
9. Chapman PB, Hauschild A, Robert C, et al; BRIM-3 Study Group: Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364: 2507-2516, 2011.
10. Flaherly KT, Infante JR, Daud A, et al: Combined BRAF and MEK inhibition in melanoma with BRAF V600E mutations. N Engl J Med 367: 1694-1703, 2012.
11. Flaherly KT, Robert C, Hersey P, et al; METRIC Study Group: Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med 367: 107-114, 2012.
12. Marchetti A, Felicioni L, Malatesta S, et al: Clinical features and outcome of patients with non-small-cell lung cancer haboring BRAF mutations. J Clin Oncol 29: 3574-3579, 2011.
13. Cardarella S, Ogino A, Nishio M, et al: Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer. Clin Cancer Res 19: 4532-4540, 2013.
14. Sasaki H, Shitara M, Yokota K, et al: Braf and erbB2 mutations correlate with smoking status in lung cancer patients. Exp Ther Med 3: 771-775, 2012.
15. Paik PK, Arcila ME, Fara M, et al: Clinical characteristics of patients with lung adenocarcinomas haboring BRAF mutations. J Clin Oncol 29: 2046-2051, 2011.
16. Sasaki H Shimizu S, Tani Y, et al: Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in Japanese lung adenocarcinoma. Lung Cancer 82: 51-54, 2013.
17. Pratilas CA, Hanrahan AJ, Halilovic E, et al: Genetic predictors of MEK dependence in non-small cell lung cancer. Cancer Res 68: 9375-9383, 2008.
18. Wan PT, Garnett MJ, Roe SM, et al; Cancer Genome Project: Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116: 855-867, 2004.
19. Ciampi R, Zhu Z and Nikiforov YE: BRAF copy number gains in thyroid tumors detected by fluorescence in situ hybridization. Endocr Pathol 16: 99-105, 2005.
20. Endo K, Sasaki H, Yano M, et al: Evaluation of the epidermal growth factor receptor gene mutation and copy number in non-small cell lung cancer with gefitinib therapy. Oncol Rep 16: 533-541, 2006.
21. Sasaki H, Okuda K, Kawano O, et al: Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Oncol Rep 18: 623-628, 2007.
22. Wang TL, Maierhofer C, Speicher MR, et al: Digital karyotyping. Proc Natl Acad Sci USA 99: 16156-16161, 2002.
23. Cardarella S, Ogino A, Nishino M, et al: Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer. Clin Cancer Res 19: 4532-4540, 2013.
24. Marchetti A, Felicioni L, Malatesta S, et al: Clinical features and outcome of patients with non-small-cell lung cancer haboring BRAF mutations. J Clin Oncol 29: 3574-3579, 2011.
25. De Oliveira Duarte Achcar R, Nikiforova MN and Yousem SA: Micropappillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile. Am J Clin Pathol 131: 694-700, 2009.
26. Rudin CM, Hong K and Streit M: Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in patient with BRAF-mutant non-small-cell lung cancer. J Thorac Oncol 8: e41-e42, 2013.
27. El-Naggar AK, Dinh M, Tucker SL, et al: Numerical chromosomal changes in DNA hypodiploid solid tumors; restricted loss and gain of certain chromosomes. Cytometry 37: 107-112, 1999.
28. Balsara BR, Sonoda G, du Manoir S, et al: Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 57: 2116-2120, 1997.
29. Ubagai T, Matsuura S, Tauchi H, et al: Coparative genomic hybridization analysis suggests a gain of chromosome 7p associated with lymph node metastasis in non-small cell lung cancer. Oncol Rep 8: 83-88, 2001.
30. Garnis C, Lockwood WW, Vucic E, et al: High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH. Int J Cancer 118: 1556-1564, 2006.